GZR-101

N/A

Report date: 2025/10/28 16:56:01

Base Information

Drug NameGZR-101
Drug Alias Name长效基础胰岛素/速效门冬胰岛素预混制剂Insulin aspart biosimilar/long acting insulin fixed dose combinationGZR33 /速效门冬胰岛素预混胰岛素预混双胰岛素复方制剂 GZR101 注射液GZR101
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonistsOrnithine decarboxylase stimulantsPhosphokinases stimulants
TargetsInsulin receptorOrnithine decarboxylasePhosphokinases
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGan & Lee Pharmaceuticals
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGan And Lee Pharmaceuticals, UsaGan & Lee Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A